Met Kinase Inhibitor E7050 Reverses Three Different...

Clinical Cancer Research 2012 / 03 Vol. 18; Iss. 6

Met Kinase Inhibitor E7050 Reverses Three Different Mechanisms of Hepatocyte Growth Factor-Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer

Wang, W., Li, Q., Takeuchi, S., Yamada, T., Koizumi, H., Nakamura, T., Matsumoto, K., Mukaida, N., Nishioka, Y., Sone, S., Nakagawa, T., Uenaka, T., Yano, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-11-1171
Date:
March, 2012
File:
PDF, 752 KB
english, 2012
Conversion to is in progress
Conversion to is failed